Form4insider filings, from the source

SEC Form 4 · accession 0001181431-15-008672

Vitae Pharmaceuticals, Inc · VTAE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jul 1, 2015
Accepted (ET)
Jul 2, 2015 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jul 1, 2015J825,000$0.00D1,786,564ISee Note 2
Common StockF4Jul 1, 2015J8,250$0.00A8,250ISee Note 4
Common StockF4Jul 1, 2015J8,250$0.00D0ISee Note 4
Common StockF7Jul 1, 2015J1,134$0.00A1,134ISee Note 7
Common StockF9Jul 1, 2015J386$0.00A386ISee Note 9
Common StockF11Jul 1, 2015J97$0.00A97ISee Note 11
Common StockF13Jul 1, 2015J1,171$0.00A1,171ISee Note 13

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses